3AO3
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | POL polyprotein | polymer | 163 | 17770.1 | 2 | UniProt (Q72498) Pfam (PF00665) | Human immunodeficiency virus 1 | |
| 2 | C, D, J, K (A, B) | CADMIUM ION | non-polymer | 112.4 | 4 | Chemie (CD) | |||
| 3 | E, L (A, B) | CHLORIDE ION | non-polymer | 35.5 | 2 | Chemie (CL) | |||
| 4 | F, M (A, B) | 3-(1,3-benzodioxol-5-yl)-1-methyl-1H-pyrazole-5-carboxylic acid | non-polymer | 246.2 | 2 | Chemie (BMC) | |||
| 5 | G, H, I, N, O... (A, B) | SULFATE ION | non-polymer | 96.1 | 6 | Chemie (SO4) | |||
| 6 | Q, R (A, B) | water | water | 18.0 | 89 | Chemie (HOH) |
Sequence modifications
A, B: 50 - 212 (UniProt: Q72498)
| PDB | External Database | Details |
|---|---|---|
| Ser 56 | Cys 771 | engineered mutation |
| Gly 123 | Ser 838 | engineered mutation |
| Ala 124 | Thr 839 | engineered mutation |
| Arg 127 | Lys 842 | engineered mutation |
| Asp 131 | Trp 846 | engineered mutation |
| Asp 139 | Phe 854 | engineered mutation |
| His 185 | Phe 900 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 35540.3 | |
| Non-Polymers* | Number of molecules | 14 |
| Total formula weight | 1589.4 | |
| All* | Total formula weight | 37129.6 |






